Literature DB >> 35111962

Hemochromatosis and Xeroderma Pigmentosum: Two (Un)Suspicious Neighbors.

Filipa Monte1, Mónica Garrido2, Tiago Pereira Guedes2, Joel Reis3, Graça Porto4,5, Isabel Pedroto1,2.   

Abstract

A 51-year-old woman, clinically diagnosed with Xeroderma pigmentosum (XP), showed abnormalities in liver enzymes, high ferritin and transferrin saturation levels, with ultrasonographic features of chronic liver disease, in addition to skin hyperpigmentation. Genetic testing confirmed the clinical hypothesis of hereditary hemochromatosis (HH). Due to the known proximity of HFE (6p22.2) and POLH (6p21.1) genes, accountable for HH and the XP-V variant, respectively, a genetic test was offered and a rare variant of the POLH gene was identified. We report the first confirmed case, to our knowledge, of a patient diagnosed both with XP and HH, in whom two mutated neighbor genes - POLH and HFE - were identified, possibly the result of genetic linkage.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  HFE; Hereditary hemochromatosis; Liver cirrhosis; POLH; Xeroderma pigmentosum

Year:  2021        PMID: 35111962      PMCID: PMC8787552          DOI: 10.1159/000513587

Source DB:  PubMed          Journal:  GE Port J Gastroenterol        ISSN: 2387-1954


  15 in total

1.  EASL clinical practice guidelines for HFE hemochromatosis.

Authors: 
Journal:  J Hepatol       Date:  2010-04-18       Impact factor: 25.083

2.  Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients.

Authors:  N Milman; P Pedersen; T á Steig; K E Byg; N Graudal; K Fenger
Journal:  Ann Hematol       Date:  2001-10-11       Impact factor: 3.673

3.  Patients with xeroderma pigmentosum complementation groups C, E and V do not have abnormal sunburn reactions.

Authors:  M Sethi; A R Lehmann; H Fawcett; M Stefanini; N Jaspers; K Mullard; S Turner; A Robson; D McGibbon; R Sarkany; H Fassihi
Journal:  Br J Dermatol       Date:  2013-12       Impact factor: 9.302

4.  A population-based study of the clinical expression of the hemochromatosis gene.

Authors:  J K Olynyk; D J Cullen; S Aquilia; E Rossi; L Summerville; L W Powell
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

5.  Neurological symptoms and natural course of xeroderma pigmentosum.

Authors:  Anu Anttinen; Leena Koulu; Eeva Nikoskelainen; Raija Portin; Timo Kurki; Matti Erkinjuntti; Nicolaas G J Jaspers; Anja Raams; Michael H L Green; Alan R Lehmann; Jonathan F Wing; Colin F Arlett; Reijo J Marttila
Journal:  Brain       Date:  2008-06-21       Impact factor: 13.501

Review 6.  Association between alcoholism and increased hepatic iron stores.

Authors:  M G Irving; J W Halliday; L W Powell
Journal:  Alcohol Clin Exp Res       Date:  1988-02       Impact factor: 3.455

7.  Screening for hemochromatosis in asymptomatic subjects with or without a family history.

Authors:  Lawrie W Powell; Jeannette L Dixon; Grant A Ramm; David M Purdie; Douglas J Lincoln; Gregory J Anderson; V Nathan Subramaniam; David G Hewett; Jeffrey W Searle; Linda M Fletcher; Darrell H Crawford; Helen Rodgers; Katrina J Allen; Juleen A Cavanaugh; Mark L Bassett
Journal:  Arch Intern Med       Date:  2006-02-13

8.  Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy.

Authors:  Wim J Kleijer; Vincent Laugel; Mark Berneburg; Tiziana Nardo; Heather Fawcett; Alexei Gratchev; Nicolaas G J Jaspers; Alain Sarasin; Miria Stefanini; Alan R Lehmann
Journal:  DNA Repair (Amst)       Date:  2008-03-10

9.  Long-term survival in patients with hereditary hemochromatosis.

Authors:  C Niederau; R Fischer; A Pürschel; W Stremmel; D Häussinger; G Strohmeyer
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

10.  Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.

Authors:  Bruce R Bacon; Paul C Adams; Kris V Kowdley; Lawrie W Powell; Anthony S Tavill
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.